BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 18717757)

  • 1. Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites.
    Kim SU; Han KH; Nam CM; Park JY; Kim DY; Chon CY; Ahn SH
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1722-7. PubMed ID: 18717757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of chronic hepatitis B virus infection: what determines prognosis after cirrhotic decompensation?
    Wei L
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1631-2. PubMed ID: 19120855
    [No Abstract]   [Full Text] [Related]  

  • 3. Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis.
    Das K; Das K; Datta S; Pal S; Hembram JR; Dhali GK; Santra A; Chowdhury A
    Liver Int; 2010 Aug; 30(7):1033-42. PubMed ID: 20492502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural history of hepatitis B virus cirrhosis after the first hepatic decompensation in Tunisia.
    Jmaa A; Ksiaa M; Ben Slama A; Kahloun A; Jmaa R; Harrabi I; Golli L; Ajmi S
    Tunis Med; 2012 Feb; 90(2):172-6. PubMed ID: 22407631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascitic fluid infection in patients with hepatitis B virus-related liver cirrhosis: culture-negative neutrocytic ascites versus spontaneous bacterial peritonitis.
    Kim SU; Kim DY; Lee CK; Park JY; Kim SH; Kim HM; Choi EH; Kim S; Han KH; Chon CY; Ahn SH
    J Gastroenterol Hepatol; 2010 Jan; 25(1):122-8. PubMed ID: 19845823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents.
    Kim CH; Um SH; Seo YS; Jung JY; Kim JD; Yim HJ; Keum B; Kim YS; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
    J Gastroenterol Hepatol; 2012 Oct; 27(10):1589-95. PubMed ID: 22554121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of compensated viral B and D cirrhosis.
    Gheorghe L; Iacob S; Simionov I; Vadan R; Gheorghe C; Iacob R; Parvulescu I; Constantinescu I
    Rom J Gastroenterol; 2005 Dec; 14(4):329-35. PubMed ID: 16400347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy.
    Bruno S; Saibeni S; Bagnardi V; Vandelli C; De Luca M; Felder M; Fracanzani AL; Prisco C; Vitaliani G; Simone L; Gaeta GB; Stanzione M; Persico M; Furlan C; Stroffolini T; Salerno F; Maisonneuve P; Almasio PL;
    Am J Gastroenterol; 2013 Jul; 108(7):1112-22. PubMed ID: 23732467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different patterns of decompensation in patients with alcoholic vs. non-alcoholic liver cirrhosis.
    Wiegand J; Kühne M; Pradat P; Mössner J; Trepo C; Tillmann HL
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1443-50. PubMed ID: 22530565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of refractory ascites development in patients with hepatitis B virus-related cirrhosis hospitalized to control ascitic decompensation.
    Seo JH; Kim SU; Park JY; Kim DY; Han KH; Chon CY; Ahn SH
    Yonsei Med J; 2013 Jan; 54(1):145-53. PubMed ID: 23225811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization.
    Yoo SH; Jang JW; Kwon JH; Jung SM; Jang B; Choi JY
    Clin Mol Hepatol; 2016 Dec; 22(4):458-465. PubMed ID: 28081589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Negative Prognostic Impact of a First Ever Episode of Spontaneous Bacterial Peritonitis in Cirrhosis and Ascites.
    Ra G; Tsien C; Renner EL; Wong FS
    J Clin Gastroenterol; 2015; 49(10):858-65. PubMed ID: 25811112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
    Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study.
    Spadaro A; Luigiano C; De Caro G; Morace C; Tortorella V; Bonfiglio C; Pagano N; Consolo P; Alibrandi A; Ajello A; Ferraù O; Freni MA
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):311-9. PubMed ID: 18043549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].
    Zhang JY; Kuai JH; Jia JD; Wang BE; Qin CY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients.
    Planas R; Ballesté B; Alvarez MA; Rivera M; Montoliu S; Galeras JA; Santos J; Coll S; Morillas RM; Solà R
    J Hepatol; 2004 May; 40(5):823-30. PubMed ID: 15094231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C.
    Elkrief L; Chouinard P; Bendersky N; Hajage D; Larroque B; Babany G; Kutala B; Francoz C; Boyer N; Moreau R; Durand F; Marcellin P; Rautou PE; Valla D
    Hepatology; 2014 Sep; 60(3):823-31. PubMed ID: 24841704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.